Aavant Research
Aavant Research's public peptide evidence is strongest on Tirzepatide and Retatrutide, with recent tests showing confirmed identity and very high purity. The signal is narrow but consistent on purity, while batch/source documentation is uneven and fill is more dispersed, especially high Tirzepatide fills and wider Retatrutide variance.
Corporate and domain records do not resolve a named U.S. counterparty, while the working storefront has shifted to irreversible crypto rails. The report maps an unauthenticated Aavant-branded storefront, Andy Peps Studio signals, and Telegram impersonation paths.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Aavant Research rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 4 Aug 2026 | Pass | Tirzepatide Aavant Research | lab name | View COA | |||
| 20 May 2026 | Pass | Tirzepatide Aavant Research | lab name | View COA | |||
| 28 Apr 2026 | Pass | Tirzepatide Aavant Research | lab name | View COA | |||
| 25 Mar 2026 | Pass | Tirzepatide Aavant Research | lab name | View COA | |||
| 25 Mar 2026 | Pass | Tirzepatide Aavant Research | lab name | View COA | |||
| 3 Mar 2026 | Pass | Retatrutide Aavant Research | lab name | View COA | |||
| 2 Mar 2026 | Pass | Tirzepatide Aavant Research | lab name | View COA | |||
| 11 Feb 2026 | Pass | Retatrutide Aavant Research | lab name | View COA | |||
| 7 Jan 2026 | Pass | Tirzepatide Aavant Research | lab name | View COA | |||
| 7 Jan 2026 | Pass | Tirzepatide Aavant Research | lab name | View COA | |||
About Aavant Research test results from Finnrick
Aavant Research is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 2 peptides and 19 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Aavant Research peptides in this dataset are Tirzepatide (12 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 19 recent tests.